Item 5.03. Amendments to Articles of Incorporation or By-laws.
On September 11, 2009, the Board of Directors of King Pharmaceuticals, Inc. (the "Company") approved and adopted amendments to the Company's existing Amended and Restated Bylaws (the "Amended and Restated Bylaws" and, as amended, the "Second Amended and Restated Bylaws") to amend Articles I and II of the Amended and Restated Bylaws to, among other things, (i) clarify the applicability of the advance notice provisions to all shareholder nominations and proposals and (ii) update the provisions of such Articles to require certain additional disclosures regarding shareholders proposing nominations or other business including, among other information, the disclosure of such shareholders' interests in the Company's securities (including derivative transactions), the disclosure of any contract, arrangement, understanding or relationship relating to a right to vote any shares of any security of the Company and the disclosure of other circumstances in which such shareholders have submitted substantially similar business for consideration at an annual or special meeting of the Company or another corporation.
A copy of the Second Amended and Restated Bylaws is attached as Exhibit 3.1 to this Current Report on Form 8-K. A copy of the Second Amended and Restated Bylaws is available free of charge from the Company. The summary description of the amendments set forth herein does not purport to be complete and is qualified in its entirety by reference to all of the provisions of the Second Amended and Restated Bylaws, including the definitions contained therein, which is hereby incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits

Exhibit No. Description
3.1 Second Amended and Restated Bylaws of King Pharmaceuticals, Inc.

---